An observational study for clinical utility and safety of bronchoalveolar lavage for interstitial lung disease that occurred during treatment for lung cancer.

An observational study for clinical utility and safety of bronchoalveolar lavage for interstitial lung disease that occurred during treatment for lung cancer. - An observational study for clinical utility and safety of bronchoalveolar lavage for interstitial lung disease that occurred during treatment for lung cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039945

Enrollment

Registered

2020-03-27

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient with lung cancer 2. patient who have developed with interstitial lung disease and who is going to receive BAL 3. Age at the time of consent acquisition is 20 years or older 4. Written informed consent for participation in this study has been obtained

Exclusion criteria

Exclusion criteria: 1. Patient difficult to receive bronchoscopy due to severe respiratory failure or unstable hemodynamics 2. Patient with high bleeding tendency 3. Pregnant 4. Other cases judged by the attending physician to be inappropriate as subjects

Design outcomes

Primary

Measure	Time frame
Comparison of cell count, cell fraction, subset of lymphocyto on BAL in patients with drug induced pneumonitis or radiation pneumonitis	—

Secondary

Measure	Time frame
Complication of BAL	—

Countries

Japan

Contacts

Public ContactTadashi Sakaguchi

Matsusaka municipal hospital Department of respiratory medicine

mchsakaguchi@city-hosp.matsusaka.mie.jp0598-23-1515

Outcome results